A Randomized Trial of Alerting to Low Glycated Hemoglobin Level in Older Adults: Results of the Low Indexes of Metabolism Intervention Trial B (LIMIT-B)

The benefit of alerting clinical staff to low plasma glycated hemoglobin (HbA1c) in patients aged 75  years and older who receive antidiabetic drugs remains uncertain.

Source: Journal of the American Medical Directors Association - October 2, 2019 Category: Health Management Authors: Nir Tsabar, Yan Press, Johanna Rotman, Bracha Klein, Yonatan Grossman, Maya Vainshtein-Tal, Sophia Eilat-Tsanani Tags: Original Study - Brief Report Source Type: research